vimarsana.com

Page 63 - செவ்வாய் கிரகம் ஆக்ஸிஜந் இல் சிட்டு வள பயன்பாடு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Panel to announce the start date of the Ramadan on Tuesday

Orion Oyj: Orion publishes Interim Report for January-March 2021 on Tuesday 27 April 2021

Orion Oyj: Orion publishes Interim Report for January-March 2021 on Tuesday 27 April 2021 Orion publishes Interim Report for January-March 2021 on Tuesday 27 April 2021 Orion will publish Interim Report for January-March 2021 on Tuesday, 27 April 2021 approximately at 12.00 noon EEST. The release and related presentation material will be available on the company s website at www.orion.fi/en/investorsafter publishing. Webcast and conference call A webcast and a conference call for analysts, investors and media will be held on Tuesday, 27 April 2021 at 13.30 EEST. The event will be held only online and by conference call. A link to the live webcast will be available on Orion s website at

Crescent sighted, Ramadan 2021 starts on Tuesday in Qatar: Awqaf

 12 Apr 2021 - 18:39 The Peninsula Online Doha: The crescent moon marking the beginning of the holy month of Ramadan was sighted in Qatar today. The Moon Sighting Committee of the Ministry of Awqaf and Islamic Affairs announced that tomorrow, Tuesday, April 13, 2021 will be the first day of the holy month of Ramadan. This came in a statement issued by the Committee after its meeting this evening at the Ministry of Awqaf and Islamic Affairs, chaired by Dr Sheikh Thaqeel Al Shammari.

PAO Group, Inc : PAOG CBD Pharmaceutical Development Update Coming Tomorrow, Tuesday April 13, 2021

PAO Group, Inc.: PAOG CBD Pharmaceutical Development Update Coming Tomorrow, Tuesday April 13, 2021 Sandusky, Ohio (Newsfile Corp. - April 12, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed a management update on the Company s ongoing CBD Pharmaceutical Development Program progress scheduled to be released next week on Tuesday, April 13, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT . PAOG is working with Veristat, a contract research organization (CRO), dedicated to the clinical advance of therapies and treatments through regulatory approval. PAOG anticipates soon announcing new breakthroughs in its CBD RespRx pharmaceutical research.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.